Jennifer Dean brings deep knowledge of both GEKA and QIAOYI, having played a key role in their development during her tenure as medmix’s Chief Financial Officer, a position she has held since the Company’s IPO in 2021. With her strategic insight and broad experience, she is well positioned to lead the Beauty Business Unit into its next phase of growth.
“I am delighted to take on the leadership of medmix’s Beauty Business Unit, a global leader in its market segments,” she commented. “Our Beauty brands, GEKA and QIAOYI, are strongly
positioned for the future, supported by close customer collaboration, high quality service, an innovative and proven product portfolio, and high performing teams.”
In her new role, Jennifer Dean will further develop and refine the Beauty portfolio and product strategy, with a strong focus on accelerating the growth of the company’s brands and strengthening its market position.